Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
GSK-923295: A Strategic Probe of Mitotic Fidelity
2026-09-04
GSK-923295 offers translational researchers a chemically defined way to interrogate CENP-E motor function, chromosome alignment, and mitotic fidelity. By integrating CENP-E inhibition with emerging evidence on CTCF-dependent centromere architecture, this article outlines a practical framework for mechanistic studies, cancer research, and preclinical decision-making.
Cholesterol for mRNA-LNP Membrane Research
2026-09-04
Learn how Cholesterol B1702 can improve the interpretability of lipid nanoparticle, membrane fluidity, and lipid metabolism experiments. This workflow translates localized p21 mRNA-LNP findings into practical formulation, assay-design, and troubleshooting decisions without overstating what the reference study directly demonstrated.
Oligo (dT) 25 Beads: Practical mRNA Workflow
2026-09-03
Oligo (dT) 25 Beads support selective capture of polyadenylated eukaryotic mRNA from total RNA or animal and plant cell or tissue samples. They are appropriate for polyA-selected mRNA workflows, but not as a general substitute for total RNA purification or for samples dominated by non-polyadenylated or prokaryotic RNA.
Liproxstatin-1 and the Next Ferroptosis Frontier
2026-09-03
Ferroptosis research is moving from redox initiation toward the plasma-membrane events that determine cell rupture. This thought-leadership guide positions Liproxstatin-1 as a mechanistic ferroptosis inhibitor for separating lipid-peroxide accumulation from membrane execution, while outlining translational strategies for renal injury and immuno-oncology models.
Kupffer Cell Plasticity in Liver Metastasis
2026-09-02
This study shows that liver metastasis-associated macrophages are maintained not only by recruited monocytes but also by local macrophage proliferation and infiltration of reprogrammed Kupffer cells. Its lineage-tracing and multiomic design clarifies why blocking monocyte-derived macrophages alone may produce limited remodeling of the immunosuppressive metastatic niche.
MAPK10–KRT16 Signaling Suppresses NSCLC Metastasis
2026-09-02
The reference study identifies a phosphorylation-dependent MAPK10/KRT16/RNF213 pathway that limits non-small cell lung cancer metastasis by promoting KRT16 ubiquitination and proteasomal degradation. Its integrated cellular, animal, and clinical evidence supports a mechanistic model for biomarker development while indicating that pathway-specific validation remains necessary before therapeutic translation.
MK-5108 (VX-689): From AURKA Biology to Assays
2026-09-01
MK-5108, also known as VX-689, is a highly selective Aurora A kinase inhibitor for cancer research. This article connects its biochemical selectivity with retinoblastoma evidence and shows how to design more informative cell and xenograft studies without overstating translational conclusions.
AMG 9810 at the Metabolism–Pain Interface
2026-09-01
TRPV1 biology is usually framed through capsaicin, heat, protons, and sensory neuron excitability. A 2024 Autophagy study adds a strategic dimension: metabolic and lysosomal stress can reorganize AMPK–SQSTM1/p62–NFE2L2 signaling through feedback, redox, pH, and calcium-dependent mechanisms. This article explains how AMG 9810 can help translational researchers separate TRPV1-driven sensory signals from stress-adaptive cellular states, while defining the evidence boundaries between pain mechanism research and cancer metabolism.
2X Taq PCR Master Mix: From Sample to Symbiont
2026-08-31
Learn how 2X Taq PCR Master Mix supports defensible genotyping, cloning, and fungal-symbiont screening. This article connects PCR chemistry with sampling bias, biological validation, and practical assay design.
Cholecystokinin Octapeptide Ammonium in B-Cell Assays
2026-08-31
Cholecystokinin octapeptide ammonium (CCK-8 ammonium) is a sulfated brain–gut peptide with receptor-selective immunomodulatory effects. This article translates the key B-cell evidence into an assay-design framework that separates receptor mechanism, cellular state, and endpoint interpretation.
Ibuprofen Workflows for Cell and COX Assays
2026-08-30
Build more informative Ibuprofen experiments by pairing dual COX inhibition with orthogonal proliferation, apoptosis, and cell-cycle readouts. This workflow also adapts protein-binding concepts from a mubritinib–albumin study without assuming that its findings automatically apply to Ibuprofen.
Acetylspiramycin in the Resistance Era
2026-08-29
Acetylspiramycin, also known as Spiramycin B, is more than a conventional macrolide comparator. Its ribosomal mechanism, activity profile in resistant Mycoplasma pneumoniae isolates, and reported immunomodulatory effects position it as a useful bridge between antimicrobial resistance research and host-pathogen biology. This article outlines how translational teams can deploy the compound in susceptibility testing, mechanistic assays, and decision-oriented research while avoiding overinterpretation of in vitro findings.
From Superoxide Signal to OA Translation
2026-08-28
A mechanistic and strategic guide to using DHE-based intracellular superoxide measurement to validate the PQQ–Nrf2–IGF1R axis in age-related osteoarthritis research and strengthen translational decision-making.
Allosteric PDK4 Inhibitors for Metabolic Disease
2026-08-28
Jeon and colleagues developed a new anthraquinone-derived series of allosteric pyruvate dehydrogenase kinase 4 inhibitors, identifying compound 8c as a potent biochemical inhibitor with activity in metabolic, allergic, and cancer-related preclinical models. The study combines medicinal chemistry, enzyme inhibition, metabolic and pharmacokinetic profiling, animal efficacy testing, and molecular docking to support PDK4 as a tractable therapeutic target while highlighting the evidence still needed for translation.
3-Deazaneplanocin (DZNep) Assay Guide
2026-08-27
A scenario-based guide to using 3-Deazaneplanocin (DZNep), SKU A1905, in viability, proliferation, apoptosis, and cancer stem cell assays. It connects formulation data, concentration and exposure choices, orthogonal readouts, and vendor-selection criteria to improve interpretation and experimental consistency.
8204 records 9/547 page Previous Next First page 上5页 678910 下5页 Last page